VandenDriessche T - Search Results

1

Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile Analysis.

Bolleyn J, Rombaut M, Nair N, Branson S, Heymans A, Chuah M, VandenDriessche T, Rogiers V, De Kock J, Vanhaecke T. Bolleyn J, et al. Among authors: vandendriessche t. Genes (Basel). 2020 Apr 29;11(5):486. doi: 10.3390/genes11050486. Genes (Basel). 2020. PMID: 32365562 Free PMC article.

2

Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.

Chuah MK, VandenDriessche T, Chang HK, Ensoli B, Morgan RA. Chuah MK, et al. Among authors: vandendriessche t. Hum Gene Ther. 1994 Dec;5(12):1467-75. doi: 10.1089/hum.1994.5.12-1467. Hum Gene Ther. 1994. PMID: 7711139

3

Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.

VandenDriessche T, Chuah MK, Chiang L, Chang HK, Ensoli B, Morgan RA. VandenDriessche T, et al. J Virol. 1995 Jul;69(7):4045-52. doi: 10.1128/JVI.69.7.4045-4052.1995. J Virol. 1995. PMID: 7769662 Free PMC article.

4

Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

Chuah MK, VandenDriessche T, Morgan RA. Chuah MK, et al. Among authors: vandendriessche t. Hum Gene Ther. 1995 Nov;6(11):1363-77. doi: 10.1089/hum.1995.6.11-1363. Hum Gene Ther. 1995. PMID: 8573610

5

Bone marrow stromal cells as targets for gene therapy of hemophilia A.

Chuah MK, Brems H, Vanslembrouck V, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. Hum Gene Ther. 1998 Feb 10;9(3):353-65. doi: 10.1089/hum.1998.9.3-353. Hum Gene Ther. 1998. PMID: 9508053

6

Anti-viral strategies.

Chuah MK, VandenDriessche T, Morgan RA. Chuah MK, et al. Among authors: vandendriessche t. Mol Cell Biol Hum Dis Ser. 1995;5:175-94. doi: 10.1007/978-94-011-0547-7_10. Mol Cell Biol Hum Dis Ser. 1995. PMID: 9532567 Review. No abstract available.

7

Gene therapy for hemophilia: hopes and hurdles.

Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. Crit Rev Oncol Hematol. 1998 Sep;28(3):153-71. doi: 10.1016/s1040-8428(98)00022-5. Crit Rev Oncol Hematol. 1998. PMID: 9793744 Review. No abstract available.

8

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

VandenDriessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, Chuah MK. VandenDriessche T, et al. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10379-84. doi: 10.1073/pnas.96.18.10379. Proc Natl Acad Sci U S A. 1999. PMID: 10468616 Free PMC article.

9

Gene therapy for hemophilia.

Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. J Gene Med. 2001 Jan-Feb;3(1):3-20. doi: 10.1002/1521-2254(200101/02)3:1<3::AID-JGM167>3.0.CO;2-H. J Gene Med. 2001. PMID: 11269333 Review.

10

Oncoretroviral and lentiviral vector-mediated gene therapy.

VandenDriessche T, Naldini L, Collen D, Chuah MK. VandenDriessche T, et al. Methods Enzymol. 2002;346:573-89. doi: 10.1016/s0076-6879(02)46078-8. Methods Enzymol. 2002. PMID: 11883092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page